No Data
Novo Nordisk A/S and Eli Lilly and Co welcome heavy bullish news! It is rumored that weight loss drugs may enter the U.S. medical insurance system.
According to reports, the government led by usa President Biden is proposing a regulation that would require payment for weight loss drugs, potentially expanding access to these medications for millions of obese americans and creating a massive new medical bill for elected President Donald Trump.
European Equities Close Lower in Tuesday Trading
Express News | The chief financial officer of novo-nordisk a/s: The direction of the White House obesity medication plan is correct.
Novo Nordisk Says White House Obesity Plan Is Step in Right Direction -- Interview
European Equities Traded in the US as American Depositary Decline in Tuesday Trading
Benzinga Market Summary: Best Buy And Kohl's Cut Outlook, Biden Admin Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs, PResident-Elect Trump Threatens Tariffs On China, Canada And Mexico